This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Bar-Ilan University, Tel Aviv University. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2012-2014
Title: Gideon Stein: Innovator in Neurodegenerative Disease Treatment
Introduction
Gideon Stein is a prominent inventor based in Rosh-Ha′ayin, Israel. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patented inventions. With a total of 2 patents, Stein's work focuses on developing conjugates that offer potential treatments for these challenging disorders.
Latest Patents
Stein's latest patents include groundbreaking conjugates for treating neurodegenerative diseases and disorders. One of his notable inventions is a conjugate comprising L-DOPA covalently linked to at least one γ-aminobutyric acid (GABA) moiety, along with an ester and/or an addition salt thereof. This invention outlines the uses of these conjugates for treating various neurodegenerative diseases or disorders, showcasing Stein's commitment to advancing medical science.
Career Highlights
Throughout his career, Gideon Stein has worked with esteemed institutions such as Ramot at Tel Aviv University Ltd. and Bar-Ilan University. His experience in these organizations has allowed him to collaborate with leading researchers and contribute to significant advancements in the field of neurodegenerative disease treatment.
Collaborations
Stein has collaborated with Ada Rephaeli, a fellow researcher, to further enhance the impact of their work in the medical field. Their partnership exemplifies the importance of collaboration in driving innovation and finding solutions to complex health issues.
Conclusion
Gideon Stein's contributions to the treatment of neurodegenerative diseases through his innovative patents highlight his role as a key inventor in this critical area of research. His work continues to inspire advancements in medical science and offers hope for those affected by these disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile